Free Trial

Guardant Health (GH) Competitors

Guardant Health logo
$50.09 +0.56 (+1.13%)
Closing price 04:00 PM Eastern
Extended Trading
$50.15 +0.06 (+0.12%)
As of 07:06 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GH vs. FMS, HIMS, OPCH, RDNT, BTSG, SHC, SGRY, PRVA, CON, and LFST

Should you be buying Guardant Health stock or one of its competitors? The main competitors of Guardant Health include Fresenius Medical Care (FMS), Hims & Hers Health (HIMS), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), and LifeStance Health Group (LFST). These companies are all part of the "healthcare" industry.

Guardant Health vs.

Guardant Health (NASDAQ:GH) and Fresenius Medical Care (NYSE:FMS) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, community ranking, profitability, institutional ownership, media sentiment, earnings, dividends and analyst recommendations.

92.6% of Guardant Health shares are owned by institutional investors. Comparatively, 8.4% of Fresenius Medical Care shares are owned by institutional investors. 6.1% of Guardant Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Guardant Health currently has a consensus price target of $53.29, suggesting a potential upside of 6.38%. Fresenius Medical Care has a consensus price target of $27.80, suggesting a potential downside of 2.95%. Given Guardant Health's stronger consensus rating and higher possible upside, equities analysts clearly believe Guardant Health is more favorable than Fresenius Medical Care.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Guardant Health
0 Sell rating(s)
0 Hold rating(s)
20 Buy rating(s)
1 Strong Buy rating(s)
3.05
Fresenius Medical Care
1 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Fresenius Medical Care received 119 more outperform votes than Guardant Health when rated by MarketBeat users. However, 71.76% of users gave Guardant Health an outperform vote while only 54.64% of users gave Fresenius Medical Care an outperform vote.

CompanyUnderperformOutperform
Guardant HealthOutperform Votes
305
71.76%
Underperform Votes
120
28.24%
Fresenius Medical CareOutperform Votes
424
54.64%
Underperform Votes
352
45.36%

In the previous week, Guardant Health had 12 more articles in the media than Fresenius Medical Care. MarketBeat recorded 18 mentions for Guardant Health and 6 mentions for Fresenius Medical Care. Fresenius Medical Care's average media sentiment score of 0.79 beat Guardant Health's score of 0.24 indicating that Fresenius Medical Care is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Guardant Health
8 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Fresenius Medical Care
4 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Fresenius Medical Care has a net margin of 3.43% compared to Guardant Health's net margin of -59.05%. Fresenius Medical Care's return on equity of 6.04% beat Guardant Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Guardant Health-59.05% -19,157.20% -25.96%
Fresenius Medical Care 3.43%6.04%2.69%

Guardant Health has a beta of 1.37, meaning that its stock price is 37% more volatile than the S&P 500. Comparatively, Fresenius Medical Care has a beta of 0.88, meaning that its stock price is 12% less volatile than the S&P 500.

Fresenius Medical Care has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Fresenius Medical Care, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Guardant Health$774.00M8.02-$479.45M-$3.39-14.78
Fresenius Medical Care$19.49B0.86$540.07M$1.1225.58

Summary

Guardant Health beats Fresenius Medical Care on 10 of the 19 factors compared between the two stocks.

Get Guardant Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for GH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GH vs. The Competition

MetricGuardant HealthMedical laboratories IndustryMedical SectorNASDAQ Exchange
Market Cap$6.21B$3.21B$5.57B$8.67B
Dividend YieldN/A31.25%5.27%4.19%
P/E Ratio-14.0714.8427.2020.16
Price / Sales8.02172.51412.92162.04
Price / CashN/A57.5638.2534.64
Price / Book37.384.857.114.72
Net Income-$479.45M-$22.21M$3.23B$247.80M
7 Day Performance9.39%3.41%4.61%3.36%
1 Month Performance20.06%7.50%13.35%9.71%
1 Year Performance66.63%15.25%31.75%14.41%

Guardant Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GH
Guardant Health
3.3216 of 5 stars
$50.09
+1.1%
$53.29
+6.4%
+72.8%$6.21B$774.00M-14.071,790Trending News
Insider Trade
FMS
Fresenius Medical Care
2.6673 of 5 stars
$28.82
+1.5%
$27.80
-3.5%
+34.1%$16.91B$19.49B23.82123,200
HIMS
Hims & Hers Health
2.5292 of 5 stars
$56.66
+0.2%
$37.67
-33.5%
+173.2%$12.68B$1.78B128.77650Trending News
Analyst Downgrade
Insider Trade
OPCH
Option Care Health
4.138 of 5 stars
$31.86
-2.5%
$35.50
+11.4%
+8.5%$5.22B$5.19B26.775,600Positive News
RDNT
RadNet
3.577 of 5 stars
$58.26
+1.3%
$69.75
+19.7%
-3.6%$4.37B$1.87B-832.178,970
BTSG
BrightSpring Health Services
0.7994 of 5 stars
$23.93
+0.5%
$23.56
-1.6%
+117.9%$4.17B$11.86B-92.0435,000News Coverage
Positive News
SHC
Sotera Health
2.7457 of 5 stars
$12.19
-0.4%
$15.80
+29.6%
+1.5%$3.46B$1.11B48.763,000Analyst Downgrade
SGRY
Surgery Partners
2.8908 of 5 stars
$23.39
-0.9%
$33.56
+43.5%
-8.2%$3.00B$3.17B-48.7312,200
PRVA
Privia Health Group
3.5533 of 5 stars
$22.83
+0.3%
$27.77
+21.6%
+35.5%$2.78B$1.80B228.32810
CON
Concentra Group Holdings Parent
N/A$21.44
-0.9%
$28.50
+32.9%
N/A$2.73B$1.93B16.0011,000Positive News
LFST
LifeStance Health Group
2.3104 of 5 stars
$5.88
-1.0%
$8.50
+44.6%
+4.1%$2.29B$1.28B-22.626,640Positive News

Related Companies and Tools


This page (NASDAQ:GH) was last updated on 6/10/2025 by MarketBeat.com Staff
From Our Partners